Matrisome analysis of NSCLC unveils clinically-important cancer-associated extracellular matrix changes
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2025
DOI: 10.1016/j.bbadis.2025.167709 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2025. Verfasst von Camila Machado Baldavira und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Lung Histomorphometry and Genomics, Department of Pathology, Faculty of Medicine, University of São Paulo, Brazil. Electronic address: …. Hauptthemen laut MEDLINE: Extracellular Matrix, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Extracellular Matrix Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: State of Sao Paulo Research Foundation, National Council for Scientific and Technological Development.
Abstract (Originalsprache)
INTRODUCTION: Non-small cell lung carcinoma (NSCLC), comprising adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC), is characterized by an active desmoplastic stroma with an accumulation of extracellular matrix (ECM) proteins. ECM remodeling is a key feature of cancer progression, but the identification of specific therapeutic targets within this compartment remains challenging. Recent studies suggest a link between increased desmoplastic stroma and malignancy in NSCLC, the role of ECM proteins in disease pathogenesis remains unclear. METHODS: We analyzed an exploratory cohort of Pan-Cancer Atlas and a study cohort to identify differentially expressed ECM proteins. Our focus was on fibrillar components (elastin, fibrillin, collagens), glycosaminoglycans (chondroitin sulfate and heparan sulfate), and matricellular proteins (SPARC). Bioinformatics analysis highlighted matrix proteins that modulate ECM functionality and structure, potentially serving as biomarkers and/or therapeutic targets. RESULTS: Adenocarcinomas exhibited an ECM enriched with abnormal elastin, chondroitin sulfate, and SPARC. Collagen IV expression in the basement membrane was reduced, while collagen III and V were prominent around tumors. LUSC showed more fibrotic ECM, leading to a stiffer microenvironment. While LUSC's basement membrane may be fragmented, it often retains more intact collagen IV compared to LUAD. High elastin expression in LUAD correlated with smaller tumors (P = 0.022), while fibrillin-2 expression was linked to T1 stage (P = 0.035) and pathological stage I (P = 0.014). In LUSC, elastin expression correlated with negative lymph nodes (P = 0.037). SPARC was an independent factor for overall survival for both subtypes (P < 0.05). CONCLUSION: This study provides insights into matrix changes in NSCLC and identifies promising candidates for targeted therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Lung Histomorphometry and Genomics, Department of Pathology, Faculty of Medicine, University of São Paulo, Brazil. Electronic address: ca.mbaldavira@gmail.com.br.
- Laboratory of Lung Histomorphometry and Genomics, Department of Pathology, Faculty of Medicine, University of São Paulo, Brazil.
- Rheumatology Division of the Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, FMUSP, São Paulo, SP, Brazil.
- Division of Pneumology, Instituto do Coração (Incor), University of São Paulo Medical School (USP), São Paulo, Brazil.
- Laboratory of Lung Histomorphometry and Genomics, Department of Pathology, Faculty of Medicine, University of São Paulo, Brazil. Electronic address: vera.capelozzi@fm.usp.br.
Förderung
- State of Sao Paulo Research Foundation
- National Council for Scientific and Technological Development
Zitieren
APA
Baldavira, C. M., Prieto, T. G., de Souza, M. L. F., Qualiotto, A. N., Velosa, A. P. P., Teodoro, W. R., Takagaki, T., Ab'Saber, A., & Capelozzi, V. L. (2025). Matrisome analysis of NSCLC unveils clinically-important cancer-associated extracellular matrix changes. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. https://doi.org/10.1016/j.bbadis.2025.167709
Vancouver
Baldavira CM, Prieto TG, de Souza MLF, Qualiotto AN, Velosa APP, Teodoro WR, et al. Matrisome analysis of NSCLC unveils clinically-important cancer-associated extracellular matrix changes. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2025. doi:10.1016/j.bbadis.2025.167709
BibTeX
@article{Baldavira2025,
author = {Baldavira, Camila Machado and Prieto, Tabatha Gutierrez and de Souza, Maria Luiza Fernezlian and Qualiotto, Aline Nery and Velosa, Ana Paula Pereira and Teodoro, Walcy Rosolia and Takagaki, Teresa and Ab'Saber, Alexandre and Capelozzi, Vera Luiza},
title = {Matrisome analysis of NSCLC unveils clinically-important cancer-associated extracellular matrix changes},
journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
year = {2025},
doi = {10.1016/j.bbadis.2025.167709}
}
EUVIMED